Decoy Therapeutics Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Decoy Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2019-06-30 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2019-03-31 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2018-06-30 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2018-03-31 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2018 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2017 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2016 was $0.00.
- Decoy Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2015 was $0.00.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2019-06-30 | $0.00 10-Q · filed 2019-07-17 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-07-17 | |
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-07-17 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-07-17 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-06 | |
| 2016-12-31 | $0.00 10-K · filed 2019-03-06 | |
| 2015-12-31 | $0.00 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |